title: Analysis of sister-chromatid exchanges.
abstract: Two requirements for the cytogenetic analysis of sister-chromatid exchanges (SCEs) in somatic cells are (1) a population of actively proliferating cells that will provide an adequate number of metaphases and (2) sister chromatids that in some way are differentially labeled or stained in the metaphases. SCEs can be recognized as abrupt discontinuities in the staining patterns of the two chromatids of a metaphase chromosome at what appear to be identical sites, with reciprocal switching from one chromatid to its sister. This protocol uses phytohemagglutinin (PHA)-stimulated cultures of blood lymphocytes as a source of proliferating cells. The cells are incubated with the thymidine analog BrdU. Slides prepared from fixed cells with BrdU-substituted chromosomes are treated with Hoechst 33258, exposed to light and heat, and then Giemsa-stained to produce differentially stained chromosomes. The chromatids with bifilar substitution exhibit a lighter purple stain than their unifilarly substituted sister chromatids.
authors.affiliation: New York Blood Center, New York, New York, USA.
authors.forename: J
authors.initials: J
authors.lastname: German
authors.forename: B
authors.initials: B
authors.lastname: Alhadeff
mesh_terms: D001399:Azure Stains; D006690:Bisbenzimidazole; D001816:Bloom Syndrome / Q000175:diagnosis / Q000235:genetics; D001973:Bromodeoxyuridine; D020732:Cytogenetic Analysis / Q000379:methods*; D005260:Female; D005826:Genetics, Medical; D006801:Humans; D008677:Metaphase / Q000235:genetics; D011247:Pregnancy; D011296:Prenatal Diagnosis; D012854:Sister Chromatid Exchange
chemical_list: D001399:Azure Stains; D001973:Bromodeoxyuridine; D006690:Bisbenzimidazole